Amarin Corp Plcuk (AMRN) EBT (2010 - 2026)
Amarin Corp Plcuk (AMRN) reported EBT of -$8.7 million for Q1 2026, up 36.0% year-over-year from -$6.4 million in Q1 2025, and down 923.83% quarter-over-quarter from -$852000.0 in Q4 2025.
Amarin Corp Plcuk (AMRN) EBT (2010 - 2026) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 17 years of EBT data on file, last reported at -$8.7 million in Q1 2026.
- EBT for Q1 2026 came in at -$8.7 million, up 36.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$31.1 million (down 203.57% YoY), and the FY2025 annual result was -$36.0 million, down 582.21% from the prior year.
- EBT retreated to -$8.7 million in Q1 2026 per AMRN's latest filing, from -$852000.0 in the prior quarter.
- Over five years, EBT peaked at $102.4 million in Q4 2022 and troughed at -$64.8 million in Q2 2022.
- A 5-year average of -$5.8 million and a median of -$8.7 million in 2026 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2024: EBT plunged 2729.34% in 2022, then jumped 998.69% in 2024.
- A 5-year view of EBT shows it stood at $102.4 million in 2022, then plunged by 102.39% to -$2.4 million in 2023, then jumped by 998.69% to $22.0 million in 2024, then slumped by 103.87% to -$852000.0 in 2025, then tumbled by 923.83% to -$8.7 million in 2026.
- Business Quant data shows AMRN's EBT at -$8.7 million in Q1 2026, -$852000.0 in Q4 2025, and -$8.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 2.89 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 8.85 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 5.99 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 1.04 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -3.50 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 2.08 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 2.58 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 3.17 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 3.24 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | -8.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.72 Mn |
| Dec 31, 2025 | -852,000.00 |
| Sep 30, 2025 | -8.12 Mn |
| Jun 30, 2025 | -13.45 Mn |
| Mar 31, 2025 | -13.63 Mn |
| Dec 31, 2024 | 22.01 Mn |
| Sep 30, 2024 | -21.53 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Mar 31, 2024 | -8.66 Mn |
| Dec 31, 2023 | -2.45 Mn |
| Sep 30, 2023 | -18.81 Mn |
| Jun 30, 2023 | -17.92 Mn |
| Mar 31, 2023 | -14.50 Mn |
| Dec 31, 2022 | 102.39 Mn |
| Sep 30, 2022 | -3.88 Mn |
| Jun 30, 2022 | -64.80 Mn |
| Mar 31, 2022 | -28.35 Mn |
| Dec 31, 2021 | 16.39 Mn |
| Sep 30, 2021 | -12.97 Mn |
| Jun 30, 2021 | 8.87 Mn |